A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study

The Safety of Infliximab Infusions in the Community Setting

(2016) James Ducharme et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review

(2010) Mark G. Ochenrider et al.   Clinical Lymphoma Myeloma & Leukemia

Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?

(2010) Shivaram Bhat et al.   INFLAMMATORY BOWEL DISEASES

Infliximab administered with shortened infusion times in a specialized IBD infusion unit: A prospective cohort study

(2010) Gert Van Assche et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid Infliximab Infusions in Pediatric Inflammatory Bowel Disease

(2009) Alyson R Yeckes et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease

(2008) Donnellan F. Clare et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

M1707 One Hour Infliximab Infusion Can Replace Two Hour Infusion in Maintenance Treatment of Crohns Disease Without Shortcomings, in Patients Treated for Up to Three Years

(2008) Ragnar Befrits et al.   GASTROENTEROLOGY

Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial

(2008) Gert Van Assche et al.   GASTROENTEROLOGY

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT